Molecular response to imatinib mesylate following relapse after allogeneic SCT for CML.
暂无分享,去创建一个
[1] H. Kantarjian,et al. Imatinib mesylate therapy for relapse after allogeneic stem cell transplantation for chronic myelogenous leukemia. , 2002, Blood.
[2] B. Druker,et al. The impact of clonal evolution on response to imatinib mesylate (STI571) in accelerated phase CML. , 2002, Blood.
[3] R. Bataille,et al. Chromosome 13 abnormalities identified by FISH analysis and serum beta2-microglobulin produce a powerful myeloma staging system for patients receiving high-dose therapy. , 2001, Blood.
[4] C. Craddock,et al. Durability of responses following donor lymphocyte infusions for patients who relapse after allogeneic stem cell transplantation for chronic myeloid leukemia , 2000 .
[5] H. Kaufmann,et al. Deletion of 13q14 remains an independent adverse prognostic variable in multiple myeloma despite its frequent detection by interphase fluorescence in situ hybridization. , 2000, Blood.
[6] H. Kittler,et al. Predictive role of interphase cytogenetics for survival of patients with multiple myeloma. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] C. Craddock,et al. Comparison of single-dose and escalating-dose regimens of donor lymphocyte infusion for relapse after allografting for chronic myeloid leukemia , 2000 .
[8] O. Haas,et al. Donor leukocyte infusion for leukemic relapse after allogeneic marrow transplantation: lack of residual donor hematopoiesis predicts aplasia. , 1997, Blood.
[9] F. Aversa,et al. Outcome for patients who relapse after allogeneic bone marrow transplantation for chronic myeloid leukemia. Chronic Leukemia Working Party. European Bone Marrow Transplantation Group , 1993 .
[10] G. Gahrton,et al. Bone marrow transplantation for chronic myeloid leukemia: long-term results. Chronic Leukemia Working Party of the European Group for Bone Marrow Transplantation. , 1993, Bone marrow transplantation.
[11] A. Chase,et al. Competitive polymerase chain reaction to estimate the number of BCR-ABL transcripts in chronic myeloid leukemia patients after bone marrow transplantation. , 1993, Blood.
[12] P. Humphries,et al. Evaluation of mixed chimerism by in vitro amplification of dinucleotide repeat sequences using the polymerase chain reaction , 1991 .
[13] A. Gratwohl,et al. Bone marrow transplantation for chronic myeloid leukemia. , 1984, Seminars in hematology.
[14] J. BotellaLlusiá,et al. [Long-term results]. , 1983, Anales de la Real Academia Nacional de Medicina.